Paediatric diabetes care during the COVID‐19 pandemic: Lessons learned in scaling up telemedicine services

Abstract

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

A Worldwide Perspective on COVID-19 and Diabetes Management in 22,820 Children from the SWEET Project: Diabetic Ketoacidosis Rates Increase and Glycemic Control Is Maintained

“…This could reflect either the facility of reporting in those newly engaged in technology and/or lacking resources among those dealing with starting and maintaining diabetes technology during high COVID-19 burden. Using technology may have enabled electronic distant review (2,3).…”

“…Particularly in those countries with a high COVID-19 mortality, special emphasis should be put on maintaining access to diabetes technology through measures like online pump and CGM starts via telemedicine (2,3). Reduced restrictions around the use of video conferencing technology for medical care, increasing use of diabetes devices that capture relevant data and can be uploaded remotely, and the increased use of video conference software in daily life will all help promote high quality, remote care.…”

“…The COVID-19 crisis has led to global disruptions in routine models of outpatient and inpatient clinical care. Many diabetes centres shifted to telemedicine, particularly in pediatric diabetology (2,3). Normal routines for people with diabetes and access to health services have also been significantly disrupted (4,5,6).…”

Care of Pediatric Patients with Diabetes During the Coronavirus Disease 2019 (COVID-19) Pandemic

“…Finally, pediatric endocrinologists at the University of Pittsburgh Medical Center in the United States provided some recommendations and insights for using telemedicine services to provide ongoing patient care during the COVID-19 pandemic 33 (March, Flint et al 2020). First, a representative from each member of the healthcare team should always be part of the development and assessment of telemedicine services that will be offered to patients.…”

COVID-19 („coronavirus disease 2019“) und Typ-1-Diabetes

“…In der gegenwärtigen COVID-19-Pandemie sind Familien von Kindern mit Diabetes besonders auf ihre Diabetestechnologie und Unterstützung durch ihre Diabetesteams angewiesen. Viele Diabeteszentren sind auf Teleme-dizin umgestiegen, insbesondere in der pädiatrischen Diabetologie [8,21]. Aber auch die normalen Routinen für Menschen mit Diabetes und der Zugang zu Gesundheitsdiensten wurden durch die Pandemie erheblich gestört [1,12,16,17].…”